ОСТРЫЙ И ХРОНИЧЕСКИЙ ПРОСТАТИТ – ЧТО ВАЖНО ДЛЯ ПРАКТИКИ?
https://doi.org/10.21886/2308-6424-2016-0-2-60-83
Аннотация
Об авторах
К.Г. Набер
Технический университет Мюнхена
Германия
94315, Германия, г.Штраубинг, Карл-Бикледер штрассе 44с
Германия
94315, Германия, г.Штраубинг, Карл-Бикледер штрассе 44с
В. Валенсик
Специализированная клиника урологии, Курпарк-Клиник
Германия
Бад-Наухайм
Германия
Бад-Наухайм
Ф.М.Е. Вагенленер
Клиника урологии, детской урологии и андрологии университетского
госпиталя Гиссена и Марбурга
Германия
Гиссен
Германия
Гиссен
Список литературы
1. Walz J, Perrotte P, Hutterer G, et al. Impact of chronic prostatitis like symptoms on the quality of life in a large group of men. BJU Int. 2007;100:1307-1311.
2. Lee SW1, Liong ML, Yuen KH, Leong WS, Cheah PY, Khan NA, Krieger JN. Adverse impact of sexual dysfunction in chronic prostatitis/chronic pelvic pain syndrome. Urology. 2008;71:79-84.
3. j L, Dy K. Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis. World J Urol. 2015 Nov 6. [Epub ahead of print]
4. Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA 1999;282(3):236-237
5. Wagenlehner FME, Elkahwaji JE, Algaba F, Bjerklund-Johansen T, Naber KG, Hartung R, Weidner W. The role of inflammation and infection in the pathogenesis of prostate carcinoma. Brit J of Urol Int 2007;100:733-737.
6. Yoon BI, Kim S, Han DS, Ha US, Lee SJ, Kim HW, Han CH, Cho YH. Acute bacterial prostatitis: how to prevent and manage chronic infection? J Infect Chemother 2012;18:444-50.
7. Schaeffer AJ. Prostatitis: US perspective. Int J Antimicr Agents 1999;11:205-216
8. Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 1968;5:492-518
9. Nickel JC, Shoskes D, Wang Y, Alexander RB, Fowler JE, Zeitlin S, O'Leary MP, Pontari MA, Schaeffer AJ, Landis JR, Nyberg L, Kusek JW, Kathleen J. Propert KJ, and the Chronic Prostatitis Collaborative Research Network Study Group. How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol 2006;176:119-124
10. Weidner W, Jantos C, Schiefer HG, Haidl G, Friedrich JJ. Semen parameters in men with and without proven chronic prostatitis. Arch Androl 1991;26:173-183
11. Mazzoli S, Cai T, Rupealta V, Gavazzi A, Pagliai RC, Mondaini N, Bartoletti R. Interleukin 8 and anti-Chlamydia trachomatis mucosal IgA as urogenital immunologic markers in patients with C. trachomatis prostatic infection. Eur Urol 2007;51:1385–1393
12. Naber K. Antibiotic treatment of chronic bacterial prostatitis. In: Nickel J (ed) Textbook of prostatitis. ISIS medical media Ltd, Oxford. 1999;285-292
13. Perletti G, Marras E, Wagenlehner FM, Magri V. Antimicrobial therapy for chronic bacterial prostatitis. Cochrane Database Syst Rev. 2013 Aug 12;8:CD009071
14. Wagenlehner FME, Lunz JC, Kees F, Wieland W, Naber KG. Serum und prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate. J Chem 2006;18:485-489
15. Wagenlehner FME, Kees F, Weidner W, Wagenlehner C, Naber KG. Concentrations of moxifloxacin in plasma and urine and penetration into prostatic fluid and ejaculate, following single oral administration of 400mg to healthy volunteers. Int J Antimcr Agents 2008;31:21-26
16. Perletti G, Wagenlehner FME, Naber KG, Magri V. Enhanced distribution of fourth-generation fluoroquinolones in prostatic tissue. Int J Antimicr Agents 2009;33:206-210
17. Barbalias GA, Nikiforidis G, Liatsikos EN. α-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol 1998;159:883-887
18. Magri V, Montanari E, Skerk V, Markotic A, Marras E, Restelli A, Naber KG, Perletti G. Fluoroquinolone–macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction. Asian J Andrology 2011;13:819-827
19. Kolumbić-Lakos A, Skerk V, Maleković G, Dujnić-Spoljarević T, Kovacic D, Pasini M, Markotić A, Magri V, Perletti G. A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study. J Chemother. 2011;23(6):350-3
20. Baert L, Herremans D. Radical transurethral prostatectomy for chronic bacterial prostatitis. In: Weidner W, Madsen PO, Schiefer HG (eds.) Prostatitis. Etiopathology, Diagnosis and Therapy. Springer, Berlin, Heidelberg, New York etc. 1994;197-205
21. de la Rosette JJ, Hubregtse MR, Meuleman EJ, Stolk-Engelaar MV, Debruyne FM. Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology 1993;41:301-307
22. Hochreiter W, Ludwig M, Weidner W et al. National Institutes of Health Chronic Prostatitis Symptom Index. Urologe [A] 2001;40:16–17
23. McNaughton Collins M, Pontari MA, O’Leary MP et al. Chronic Prostatitis Collaborative Research Network. Quality of life is impaired in men with chronic prostatitis. J Gen Intern Med 2001;16(10):656-662
24. McNaughton Collins M, MacDonald R, Wilt TJ. Diagnosisand treatment of chronic abacterial prostatitis. Ann Intern Med 2000;133(5):367-381
25. Hetrick DC, Ciol MA, Rothman I et al. Musculoskeletal dysfunction in men with chronic pelvic pain syndrome type III. J Urol 2003;170(3):828-831
26. Hochreiter WW, Nadler RB, Koch AE et al. Evaluationof the cytokines interleukin 8 and epithelial neutrophilactivating peptide 78 as indicators of inflammation in prostatic secretions. Urology 2000;56(6):1025-1029.
27. Anothaisintawee T, Attia J, Nickel JC, Thammakraisorn S, Numthavaj P, McEvoy M, Thakkinstian A. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA 2011;305:78-86
28. Shoskes DA, Nickel JC, Dolinga R, Prots D. Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology 2009;73:538–542
29. Magri V, Wagenlehner F, Perletti G, Schneider S, Marras E, Naber KG, Weidner W. Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts: Sexual function domain improves correlations. J Urol 2010;184:2339-2345
30. Shoskes DA, Nickel JC, Kattan MW. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: A prospective study using UPOINT. Urology 2010;75:1249-1253
31. Magri V, Marras E, Restelli A, Wagenlehner FME, Perletti G. Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients. Exper Ther Med 2015;9:658-666
Рецензия
Для цитирования:
Набер К., Валенсик В., Вагенленер Ф. ОСТРЫЙ И ХРОНИЧЕСКИЙ ПРОСТАТИТ – ЧТО ВАЖНО ДЛЯ ПРАКТИКИ? Вестник урологии. 2016;(2):60-83. https://doi.org/10.21886/2308-6424-2016-0-2-60-83
For citation:
Naber K., Vahlensieck W., Wagenlehner F. AKUTE UND CHRONISCHE PROSTATITIS - WAS IST WICHTIG FÜR DIE PRAXIS? Urology Herald. 2016;(2):60-83. (In Russ.) https://doi.org/10.21886/2308-6424-2016-0-2-60-83
Просмотров: 2568
Послать статью по эл. почте 
